California Data Exchange Stakeholders Identify Gaps in QHIO Program
During listening tour, stakeholders describe mixed experiences with selecting, implementing, and effectively exchanging data using a QHIO
Read More
The Top Patient Engagement Tools for Behavioral Health Organizations
[Sponsored] Patient engagement is a clinical necessity in behavioral healthcare. Mental health treatment requires long-term commitment, consistent communication and deep trust between providers and patients. The post The Top Patient Engagement Tools for Behavioral Health Organizations appeared first on MedCity News.
Theravance Drug Fails Another Pivotal Test, This Time Sparking Restructuring That Ends R&D
Ampreloxetine’s Phase 3 failure in multiple system atrophy is the third disappointing clinical trial outcome for the Theravance Biopharma drug. The biotech will now wind down all R&D and explore options that could include the sale of the company. The post Theravance Drug Fails Another Pivotal Test, This Time Sparking Restructuring That Ends R&D appeared…
Medication Adherence and Deprescribing Programs Aren’t Enough for Today’s Polypharmacy Patients
By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used — not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health. The post Medication Adherence and Deprescribing Programs Aren’t Enough for Today’s Polypharmacy Patients appeared first on MedCity…
Why 131 Hospitals Are Suing HHS Over Alleged Underpayment
A group of 131 hospitals has sued HHS over a CMS policy they say improperly reduces Medicare disproportionate share hospital (DSH) payments. The lawsuit is the latest in a decade-long legal battle over how the agency counts patient days and calculates payments for safety net hospitals. The post Why 131 Hospitals Are Suing HHS Over…
Applied Therapeutics Drug Is Denied FDA Approval in Rare Inherited Metabolic Disease
The FDA cited deficiencies in its govorestat’s application in galactosemia, a rare metabolic disease, Applied Therapeutics said. The biotech is still on track to submit a separate application for the drug in sorbitol dehydrogenase (SORD) deficiency, another rare disease that has no FDA-approved therapies. The post Applied Therapeutics Drug Is Denied FDA Approval in Rare…
Have Job-Based Health Coverage at 65? You May Still Want To Sign Up for Medicare
When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. It also covered related pain management and physical therapy after she returned home to New York City. The bills totaled more than $100,000. The real estate lawyer, now…
Technology Evolution: Why Clinicians Must Expand Their Sources of Data
Healthcare today requires more than the partial snapshot offered by legacy technology. By integrating diverse data sources such as wearables, claims, communications, and ADT feeds, clinicians gain a comprehensive, real-time view of their patients’ health. The post Technology Evolution: Why Clinicians Must Expand Their Sources of Data appeared first on MedCity News.
AcademyHealth: AHRQ Is ‘Funded But Frozen’
Organization’s CEO Aaron Carroll says that despite congressional funding, Agency for Healthcare Research and Quality is not issuing new grants
Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
One afternoon in late 2024, a sixth-grader nicknamed Bug came home from school with an announcement to make. Bug, who was assigned female at birth, told his parents he was a boy — and would be using he/him pronouns. “OK, cool,” his mother, J, remembered saying. (J asked to be identified by only her first…